47.37 USD
+2.01 (+4.43%)
BRKR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. BRKR has a medium profitability rating, but doesn't score so well on its financial health evaluation. BRKR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
BRKR had positive earnings in the past year.
In the past year BRKR had a positive cash flow from operations.
BRKR had positive earnings in each of the past 5 years.
BRKR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of BRKR (-0.37%) is better than 64.91% of its industry peers.
BRKR has a better Return On Equity (-0.97%) than 64.91% of its industry peers.
BRKR has a better Return On Invested Capital (4.01%) than 68.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRKR is below the industry average of 13.99%.
The 3 year average ROIC (9.30%) for BRKR is well above the current ROIC(4.01%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
In the last couple of years the Profit Margin of BRKR has declined.
Looking at the Operating Margin, with a value of 8.99%, BRKR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Operating Margin of BRKR has declined.
BRKR has a Gross Margin (48.00%) which is comparable to the rest of the industry.
BRKR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKR is destroying value.
The number of shares outstanding for BRKR has been increased compared to 1 year ago.
Compared to 5 years ago, BRKR has less shares outstanding
The debt/assets ratio for BRKR is higher compared to a year ago.
2.2 Solvency
BRKR has an Altman-Z score of 2.44. This is not the best score and indicates that BRKR is in the grey zone with still only limited risk for bankruptcy at the moment.
BRKR's Altman-Z score of 2.44 is in line compared to the rest of the industry. BRKR outperforms 56.14% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that BRKR is somewhat dependend on debt financing.
The Debt to Equity ratio of BRKR (0.82) is worse than 73.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.44 |
ROIC/WACC0.42
WACC9.65%
2.3 Liquidity
BRKR has a Current Ratio of 1.85. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
BRKR's Current ratio of 1.85 is on the low side compared to the rest of the industry. BRKR is outperformed by 61.40% of its industry peers.
A Quick Ratio of 0.89 indicates that BRKR may have some problems paying its short term obligations.
BRKR has a worse Quick ratio (0.89) than 87.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
The earnings per share for BRKR have decreased strongly by -18.37% in the last year.
BRKR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
The Revenue has been growing slightly by 6.10% in the past year.
Measured over the past years, BRKR shows a quite strong growth in Revenue. The Revenue has been growing by 10.19% on average per year.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
The Earnings Per Share is expected to grow by 4.96% on average over the next years.
Based on estimates for the next years, BRKR will show a small growth in Revenue. The Revenue will grow by 3.14% on average per year.
EPS Next Y-20.74%
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
EPS Next 5Y4.96%
Revenue Next Year1.96%
Revenue Next 2Y1.6%
Revenue Next 3Y2.61%
Revenue Next 5Y3.14%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
BRKR is valuated rather expensively with a Price/Earnings ratio of 23.68.
BRKR's Price/Earnings ratio is rather cheap when compared to the industry. BRKR is cheaper than 82.46% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.29, BRKR is valued at the same level.
The Price/Forward Earnings ratio is 22.03, which indicates a rather expensive current valuation of BRKR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 84.21% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.51, BRKR is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.69 | ||
| Fwd PE | 22.03 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRKR is valued cheaply inside the industry as 84.21% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 16.42 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)2.65
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
5. Dividend
5.1 Amount
BRKR has a yearly dividend return of 0.41%, which is pretty low.
Compared to an average industry Dividend Yield of 0.46, BRKR pays a better dividend. On top of this BRKR pays more dividend than 89.47% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, BRKR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
BRKR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
The earnings of BRKR are negative and hence is the payout ratio. BRKR will probably not be able to sustain this dividend level.
The dividend of BRKR is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
NASDAQ:BRKR (12/10/2025, 10:19:58 AM)
47.37
+2.01 (+4.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners90.24%
Inst Owner Change6.35%
Ins Owners26.95%
Ins Owner Change0.17%
Market Cap7.20B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts78
Price Target47.46 (0.19%)
Short Float %12.99%
Short Ratio4.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr Years0
Div Non Decr Years8
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)4.3%
PT rev (3m)3.33%
EPS NQ rev (1m)-6.25%
EPS NQ rev (3m)-24.54%
EPS NY rev (1m)-4.23%
EPS NY rev (3m)-6.92%
Revenue NQ rev (1m)-0.8%
Revenue NQ rev (3m)-3.98%
Revenue NY rev (1m)-0.63%
Revenue NY rev (3m)-0.97%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.69 | ||
| Fwd PE | 22.03 | ||
| P/S | 2.09 | ||
| P/FCF | N/A | ||
| P/OCF | 76.32 | ||
| P/B | 2.96 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.42 |
EPS(TTM)2
EY4.22%
EPS(NY)2.15
Fwd EY4.54%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY1.31%
SpS22.63
BVpS16.01
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)2.65
Graham Number26.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.44 |
F-Score5
WACC9.65%
ROIC/WACC0.42
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-20.74%
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
EPS Next 5Y4.96%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year1.96%
Revenue Next 2Y1.6%
Revenue Next 3Y2.61%
Revenue Next 5Y3.14%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year14.16%
EBIT Next 3Y13.08%
EBIT Next 5Y8.97%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP / BRKR FAQ
Can you provide the ChartMill fundamental rating for BRUKER CORP?
ChartMill assigns a fundamental rating of 4 / 10 to BRKR.
What is the valuation status of BRUKER CORP (BRKR) stock?
ChartMill assigns a valuation rating of 3 / 10 to BRUKER CORP (BRKR). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP?
BRUKER CORP (BRKR) has a profitability rating of 5 / 10.
What is the expected EPS growth for BRUKER CORP (BRKR) stock?
The Earnings per Share (EPS) of BRUKER CORP (BRKR) is expected to decline by -20.74% in the next year.
Is the dividend of BRUKER CORP sustainable?
The dividend rating of BRUKER CORP (BRKR) is 4 / 10 and the dividend payout ratio is -96.62%.